SCHEMBL22103530

SCHEMBL22103530

COc1cc(C2CC2)cc(F)c1C=O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 2/20 0.39
KDM1A O60341 2/20 0.36
PRKDC P78527 1/20 0.35
PDE4A P27815 2/20 0.35
PDE4B Q07343 2/20 0.35
PDE4C Q08493 2/20 0.35
PDE4D Q08499 2/20 0.35
ADAMTS5 Q9UNA0 3/20 0.34
ALDH1A1 P00352 2/20 0.34
TSHR P16473 2/20 0.34
KDM4E B2RXH2 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
QDPR P09417 2/20 0.34
ADAM17 P78536 1/20 0.34
PTAFR P25105 2/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12174445 0.88 ERN1 (0.44) ERN1PRKDCPDE4APDE4BPDE4C
SCHEMBL14641983 0.83 ERN1 (0.43) ERN1PRKDCPDE4APDE4BPDE4C
SCHEMBL24439732 0.82 ESR2 (0.31)
SCHEMBL24313733 0.81 DRD1 (0.34) PDE4APDE4BPDE4CPDE4D
SCHEMBL24313743 0.80 HTR2A (0.42) ERN1PDE4APDE4BPDE4CPDE4D
SCHEMBL18366 0.75 ERN1 (0.46) ERN1PRKDCALDH1A1TSHRKDM4E
SCHEMBL24313611 0.75 ESR2 (0.36) ERN1QDPRMAPT
SCHEMBL14302791 0.75
SCHEMBL24313909 0.74 NPY5R (0.30)
SCHEMBL1645590 0.74 ERN1 (0.62) ERN1PRKDCALDH1A1TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed
WO-2020123395-A1 2-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2020-06-18 WO disclosed